Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Research and development | 156,786 | — | 136,392 | — |
| Selling, general and administrative | 198,598 | — | 174,268 | — |
| Operating expenses | 355,384 | — | 310,660 | — |
| Net income | −384,430 | −475,452 | −294,797 | −356,619 |
| Earnings per share | −0.07 | — | −0.05 | — |
| Earnings per share, diluted | −0.07 | — | −0.05 | — |
| Weighted average shares | 5m | — | 5m | — |
| Weighted average shares, diluted | 5m | — | 5m | — |
| Metric | Sep 17, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 193,017 | — | 601,010 | 390,276 | — | 962,923 |
| Current assets | — | 1m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 681,170 |
| — |
| — |
| — |
| Total assets | — | 1m | — | 681,170 | — | — | — |
| Current liabilities | — | 3m | — | 2m | — | — | — |
| Total liabilities | — | 3m | — | 2m | — | — | — |
| Equity | — | −2m | −1m | −919,235 | −136,590 | 155,586 | 509,584 |
| Shares outstanding | 15m | 5m | — | 5m | — | — | — |
| Shares issued | — | 5m | — | 5m | 5m | — | — |